The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Pemphigus
Open accessAbstract
Pemphigus is a group of IgG-mediated autoimmune diseases of stratified squamous epithelia, such as the skin and oral mucosa, in which acantholysis (the loss of cell adhesion) causes blisters and erosions. Pemphigus has three major subtypes: pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. IgG autoantibodies are characteristically raised against desmoglein 1 and desmoglein 3, which are cell–cell adhesion molecules found in desmosomes. The sites of blister formation can be physiologically explained by the anti-desmoglein autoantibody profile and tissue-specific expression pattern of desmoglein isoforms. The pathophysiological roles of T cells and B cells have been characterized in mouse models of pemphigus and patients, revealing insights into the mechanisms of autoimmunity. Diagnosis is based on clinical manifestations and confirmed with histological and immunochemical testing. The current first-line treatment is systemic corticosteroids and adjuvant therapies, including immunosuppressive agents, intravenous immunoglobulin and plasmapheresis. Rituximab, a monoclonal antibody against CD20+ B cells, is a promising therapeutic option that may soon become first-line therapy. Pemphigus is one of the best-characterized human autoimmune diseases and provides an ideal paradigm for both basic and clinical research, especially towards the development of antigen-specific immune suppression treatments for autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00112-k · Cited by 7,643
Weng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300
Paraneoplastic Pemphigus: An Autoimmune Mucocutaneous Disease Associated with Neoplasia
Anhalt, G. J., Kim, S., Stanley, J. R., Korman, N. J., Jabs, D. A., Kory, M., Izumi, H., Ratrie, H., Mutasim, D., Ariss-Abdo, L., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199012203232503 · Cited by 1,035
Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion
Amagai, M., Klaus-Kovtun, V., & Stanley, J. R. (1991) · Cell · doi:10.1016/0092-8674(91)90360-b · Cited by 1,021
Self-citationReengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Ellebrecht, C. T., Bhoj, V. G., Nace, A., Choi, E. J., Mao, X., Cho, M. J., Di Zenzo, G., Lanzavecchia, A., Seykora, J. T., Cotsarelis, G., et al. (2016) · Science · doi:10.1126/science.aaf6756 · Cited by 738
Self-citationWu, J., Edberg, J. C., Redecha, P. B., Bansal, V, Guyre, P. M., Coleman, K., Salmon, J. E., & Kimberly, R. P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119616 · Cited by 711
C-Cadherin Ectodomain Structure and Implications for Cell Adhesion Mechanisms
Boggon, T. J., Murray, J., Chappuis-Flament, S., Wong, E., Gumbiner, B. M., & Shapiro, L. (2002) · Science · doi:10.1126/science.1071559 · Cited by 669
Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG from Patients with the Disease
Anhalt, G. J., Labib, R. S., Voorhees, J. J., Beals, T. F., & Diaz, L. A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198205203062001 · Cited by 663
Langan, S. M., Smeeth, L., Hubbard, R., Fleming, K. M., Smith, C. J. P., & West, J. (2008) · BMJ · doi:10.1136/bmj.a180 · Cited by 632
Joly, P., Maho-Vaillant, M., Prost-Squarcioni, C., Hebert, V., Houivet, E., Calbo, S., Caillot, F., Golinski, M. L., Labeille, B., Picard-Dahan, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30070-3 · Cited by 623
A common missense variant in NUDT15 confers susceptibility to thiopurine-induced leukopenia
Yang, S.-K., Hong, M., Baek, J., Choi, H., Zhao, W., Jung, Y., Haritunians, T., Ye, B. D., Kim, K.-J., Park, S. H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3060 · Cited by 549
BAFF selectively enhances the survival of plasmablasts generated from human memory B cells
Avery, D. T., Kalled, S. L., Ellyard, J. I., Ambrose, C., Bixler, S. A., Thien, M., Brink, R., Mackay, F., Hodgkin, P. D., & Tangye, S. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18025 · Cited by 509
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1
Amagai, M., Matsuyoshi, N., Wang, Z. H., Andl, C., & Stanley, J. R. (2000) · Nature Medicine · doi:10.1038/81385 · Cited by 493
Self-citationA Single Cycle of Rituximab for the Treatment of Severe Pemphigus
Joly, P., Mouquet, H., Roujeau, J.-C., D'Incan, M., Gilbert, D., Jacquot, S., Gougeon, M.-L., Bedane, C., Muller, R., Dreno, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa067752 · Cited by 466
Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin Syndrome
Stanley, J. R., & Amagai, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061111 · Cited by 466
Self-citationTreatment of Pemphigus Vulgaris with Rituximab and Intravenous Immune Globulin
Ahmed, A. R., Spigelman, Z., Cavacini, L. A., & Posner, M. R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062930 · Cited by 456
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Buch, M. H., Smolen, J. S., Betteridge, N., Breedveld, F. C., Burmester, G., Dörner, T., Ferraccioli, G., Gottenberg, J.-E., Isaacs, J., Kvien, T. K., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144998 · Cited by 453
Aalberse, R. C., & Schuurman, J. (2002) · Immunology · doi:10.1046/j.0019-2805.2001.01341.x · Cited by 449
Rituximab-Dependent Cytotoxicity by Natural Killer Cells
Dall’Ozzo, S., Tartas, S., Paintaud, G., Cartron, G., Colombat, P., Bardos, P., Watier, H., & Thibault, G. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2862 · Cited by 434
Anolik, J. H., Campbell, D., Felgar, R. E., Young, F., Sanz, I., Rosenblatt, J., & Looney, R. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10764 · Cited by 429
Kotlyar, D. S., Lewis, J. D., Beaugerie, L., Tierney, A., Brensinger, C. M., Gisbert, J. P., Loftus, E. V., Peyrin-Biroulet, L., Blonski, W. C., Van Domselaar, M., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.05.015 · Cited by 414
Probst, C., Schlumberger, W., Stöcker, W., Recke, A., Schmidt, E., Hashimoto, T., Zhu, X. J., Zillikens, D., & Komorowski, L. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.08.022 · Cited by 406
Self-citationBilgiç Temel, A., Bassorgun, C. I., Akman-Karakaş, A., Alpsoy, E., & Uzun, S. (2017) · Case Reports in Dermatology · doi:10.1159/000452828 · Cited by 363
Koch, P. J., Walsh, M. J., Schmelz, M., Goldschmidt, M. D., Zimbelmann, R., & Franke, W. W. (1990) · PubMed · Cited by 329
Tsunoda, K., Ota, T., Aoki, M., Yamada, T., Nagai, T., Nakagawa, T., Koyasu, S., Nishikawa, T., & Amagai, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.2170 · Cited by 313
Self-citationAmagai, M., Nishikawa, T., Nousari, H. C., Anhalt, G. J., & Hashimoto, T. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3647 · Cited by 312
Self-citationProspective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany
Bertram, F., Bröcker, E., Zillikens, D., & Schmidt, E. (2009) · JDDG: Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06976.x · Cited by 283
Self-citationLutterotti, A., Yousef, S., Sputtek, A., Stürner, K. H., Stellmann, J.-P., Breiden, P., Reinhardt, S., Schulze, C., Bester, M., Heesen, C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006168 · Cited by 281
The antiinflammatory activity of IgG: the intravenous IgG paradox
Nimmerjahn, F., & Ravetch, J. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061788 · Cited by 280
Robson, R. A., Cecka, J. M., Opelz, G., Budde, M., & Sacks, S. T. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.01125.x · Cited by 266
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Li, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24394 · Cited by 264
A randomized double-blind trial of intravenous immunoglobulin for pemphigus
Amagai, M., Ikeda, S., Shimizu, H., Iizuka, H., Hanada, K., Aiba, S., Kaneko, F., Izaki, S., Tamaki, K., Ikezawa, Z., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.09.052 · Cited by 255
Self-citationUse of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus
Amagai, M., Tsunoda, K., Suzuki, H., Nishifuji, K., Koyasu, S., & Nishikawa, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8748 · Cited by 255
Self-citationColliou, N., Picard, D., Caillot, F., Calbo, S., Le Corre, S., Lim, A., Lemercier, B., Le Mauff, B., Maho-Vaillant, M., Jacquot, S., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005166 · Cited by 249
The Mechanism of Respiratory Failure in Paraneoplastic Pemphigus
Nousari, H. C., Deterding, R., Wojtczack, H., Aho, S., Uitto, J., Hashimoto, T., & Anhalt, G. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905063401805 · Cited by 247
Reliability and Convergent Validity of Two Outcome Instruments for Pemphigus
Rosenbach, M. A., Murrell, D. F., Bystryn, J. C., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.72 · Cited by 241
Payne, A. S., Ishii, K., Kacir, S., Lin, C., Li, H., Hanakawa, Y., Tsunoda, K., Amagai, M., Stanley, J. R., & Siegel, D. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524185 · Cited by 234
Self-citationp38MAPK inhibition prevents disease in pemphigus vulgaris mice
Berkowitz, P., Hu, P., Warren, S., Liu, Z., Diaz, L. A., & Rubenstein, D. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602973103 · Cited by 228
Ahmed, A. R., Yunis, E. J., Khatri, K., Wagner, R., Notani, G., Awdeh, Z., & Alper, C. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.19.7658 · Cited by 227
Pisanti, S., Sharav, Y., Kaufman, E., & Posner, L. N. (1974) · Oral Surgery, Oral Medicine, Oral Pathology · doi:10.1016/0030-4220(74)90365-x · Cited by 221
Calkins, C. C., Setzer, S. V., Jennings, J. M., Summers, S., Tsunoda, K., Amagai, M., & Kowalczyk, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512447200 · Cited by 215
Self-citationTony, H.-P., Burmester, G., Schulze-Koops, H., Grunke, M., Henes, J., Kötter, I., Haas, J., Unger, L., Lovric, S., Haubitz, M., et al. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3337 · Cited by 212
Farag, S. S., Flinn, I. W., Modali, R., Lehman, T. A., Young, D., & Byrd, J. C. (2004) · Blood · doi:10.1182/blood-2003-07-2548 · Cited by 210
Coenen, M. J. H., de Jong, D. J., van Marrewijk, C. J., Derijks, L. J. J., Vermeulen, S. H., Wong, D. R., Klungel, O. H., Verbeek, A. L. M., Hooymans, P. M., Peters, W. H. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.06.002 · Cited by 199
Alpsoy, E., Akman-Karakas, A., & Uzun, S. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-014-1531-1 · Cited by 190
Pemphigus vulgaris identifies plakoglobin as key suppressor of c‐Myc in the skin
Williamson, L., Raess, N. A., Caldelari, R., Zakher, A., de Bruin, A., Posthaus, H., Bolli, R., Hunziker, T., Suter, M. M., & Müller, E. J. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601224 · Cited by 181
Autoimmunity against desmosomal cadherins in pemphigus
Amagai, M. (1999) · Journal of Dermatological Science · doi:10.1016/s0923-1811(99)00016-x · Cited by 180
Self-citationEfficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens
Wang, H., Liu, C., Li, Y., & Huang, Y. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-2116 · Cited by 175
Nguyen, V. T., Ndoye, A., Shultz, L. D., Pittelkow, M. R., & Grando, S. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10305 · Cited by 175
Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface
Di Zenzo, G., Di Lullo, G., Corti, D., Calabresi, V., Sinistro, A., Vanzetta, F., Didona, B., Cianchini, G., Hertl, M., Eming, R., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64413 · Cited by 174
Self-citationLin, M. S., Swartz, S. J., Lopez, A., Ding, X., Fernandez-Vina, M. A., Stastny, P., Fairley, J. A., & Diaz, L. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119130 · Cited by 174
Structural basis of adhesive binding by desmocollins and desmogleins
Harrison, O. J., Brasch, J., Lasso, G., Katsamba, P. S., Ahlsen, G., Honig, B., & Shapiro, L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606272113 · Cited by 172
Veldman, C., Höhne, A., Dieckmann, D., Schuler, G., & Hertl, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6468 · Cited by 164
Prevention and management of glucocorticoid-induced side effects: A comprehensive review
Caplan, A. S., Fett, N. M., Rosenbach, M. A., Werth, V. P., & Micheletti, R. G. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.01.062 · Cited by 159
Inhibition of Rho A activity causes pemphigus skin blistering
Waschke, J., Spindler, V., Bruggeman, P., Zillikens, D., Schmidt, G., & Drenckhahn, D. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200605125 · Cited by 158
Self-citationDesmoglein 3 anchors telogen hair in the follicle
Koch, P. J., Mahoney, M. G., Cotsarelis, G., Rothenberger, K., Lavker, R. M., & Stanley, J. R. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.17.2529 · Cited by 156
Peters, A. L., & Noorden, C. J. F. V. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953828 · Cited by 154
Pemphigus Vulgaris IgG Directly Inhibit Desmoglein 3-Mediated Transinteraction
Heupel, W.-M., Zillikens, D., Drenckhahn, D., & Waschke, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1825 · Cited by 136
Self-citationPredominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus
Futei, Y., Amagai, M., Ishii, K., Kuroda-Kinoshita, K., Ohya, K., & Nishikawa, T. (2001) · Journal of Dermatological Science · doi:10.1016/s0923-1811(00)00158-4 · Cited by 134
Self-citationVeldman, C. M., Stauber, A., Waßmuth, R., Uter, W. J. C., Schuler, G., & Hertl, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.635 · Cited by 130
Recognition of Desmoglein 3 by Autoreactive T Cells in Pemphigus Vulgaris Patients and Normals
Hertl, M., Amagai, M., Sundaram, H. A., Stanley, J. R., Ishii, K., & Katz, S. I. (1998) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1998.00086.x · Cited by 129
Self-citationThe Role of FcRn in Antigen Presentation
Baker, K., Räth, T., Pyzik, M., & Blumberg, R. S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00408 · Cited by 127
Protection against Pemphigus Foliaceus by Desmoglein 3 in Neonates
Wu, H. G., Wang, Z. H., Yan, A. C., Lyle, S. R., Fakharzadeh, S. S., Wahl, J. K., Wheelock, M. J., Ishikawa, H., Uitto, J., Amagai, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200007063430105 · Cited by 124
Self-citationMoraes, M. E., Fernández-Viña, M., Lázaro, A., Diaz, L. A., Filho, G. H., Friedman, H., Rivitti, E. A., Aoki, V., Stastny, P., & Moraes, J. R. (1997) · Tissue Antigens · doi:10.1111/j.1399-0039.1997.tb02707.x · Cited by 120
Pemphigus in Hartford County, Connecticut, From 1972 to 1977
Simon, D. G. (1980) · Archives of Dermatology · doi:10.1001/archderm.1980.01640330073017 · Cited by 110
Persistence of Anti-Desmoglein 3 IgG+ B-Cell Clones in Pemphigus Patients over Years
Hammers, C. M., Chen, J., Lin, C., Kacir, S., Siegel, D. L., Payne, A. S., & Stanley, J. R. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.291 · Cited by 110
Self-citationSchepens, I., Jaunin, F., Begré, N., Läderach, U., Marcus, K., Hashimoto, T., Favre, B., & Borradori, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012250 · Cited by 109
Culton, D. A., Qian, Y., Li, N., Rubenstein, D., Aoki, V., Filho, G. H., Rivitti, E. A., & Diaz, L. A. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.08.003 · Cited by 108
Pemphigus Vulgaris IgG and Methylprednisolone Exhibit Reciprocal Effects on Keratinocytes
Nguyen, V. T., Arredondo, J., Chernyavsky, A. I., Kitajima, Y., Pittelkow, M. R., & Grando, S. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309000200 · Cited by 108
p38MAPK Signaling and Desmoglein-3 Internalization Are Linked Events in Pemphigus Acantholysis
Jolly, P. S., Berkowitz, P., Bektas, M., Lee, H.-E., Chua, M., Diaz, L. A., & Rubenstein, D. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.087999 · Cited by 105
Sarig, O., Bercovici, S., Zoller, L., Goldberg, I., Indelman, M., Nahum, S., Israeli, S., Sagiv, N., de Morentin, H. M., Katz, O., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.46 · Cited by 101
Self-citationQian, Y., Jeong, J. S. Y., Maldonado, M., Valenzuela, J. G., Gomes, R., Teixeira, C., Evangelista, F., Qaqish, B. F., Aoki, V., Hans, G., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200842 · Cited by 100
Desmoglein 3–specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice
Takahashi, H., Kouno, M., Nagao, K., Wada, N. A., Hata, T., Nishimoto, S., Iwakura, Y., Yoshimura, A., Yamada, T., Kuwana, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57379 · Cited by 96
Self-citationPappas, D. A., Hooper, M. M., Kremer, J. M., Reed, G. W., Shan, Y., Wenkert, D., Greenberg, J. D., & Curtis, J. R. (2015) · Arthritis Care & Research · doi:10.1002/acr.22628 · Cited by 95
Monopathogenic vs multipathogenic explanations of pemphigus pathophysiology
Ahmed, A. R., Carrozzo, M., Caux, F. A., Cirillo, N., Dmochowski, M., Alonso, A. E., Gniadecki, R., Hertl, M., López-Zabalza, M. J., Lotti, R., et al. (2016) · Experimental Dermatology · doi:10.1111/exd.13106 · Cited by 91
Association between HLA‐DRB1 polymorphisms and pemphigus vulgaris: a meta‐analysis
Yan, L., Wang, J., & Zeng, K. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11040.x · Cited by 89
Kasperkiewicz, M., Shimanovich, I., Meier, M., Schumacher, N., Westermann, L., Kramer, J., Zillikens, D., & Schmidt, E. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10585.x · Cited by 86
Self-citationp38 MAPK Activation Is Downstream of the Loss of Intercellular Adhesion in Pemphigus Vulgaris
Mao, X., Sano, Y., Park, J. M., & Payne, A. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.172874 · Cited by 85
Self-citationDevelopment of a Quality-of-Life Instrument for Autoimmune Bullous Disease
Sebaratnam, D. F., Hanna, A. M., Chee, S., et al. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.4972 · Cited by 84
Parameswaran, A., Attwood, K. M., Sato, R., Seiffert-Sinha, K., & Sinha, A. A. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13433 · Cited by 76
Ohyama, B., Nishifuji, K., Chan, P. T., Kawaguchi, A., Yamashita, T., Ishii, N., Hamada, T., Dainichi, T., Koga, H., Tsuruta, D., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.448 · Cited by 74
Self-citationEming, R., Hennerici, T., Bäcklund, J., Feliciani, C., Visconti, K. C., Willenborg, S., Wohde, J., Holmdahl, R., Sønderstrup, G., & Hertl, M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401081 · Cited by 73
Tsuchisaka, A., Numata, S., Teye, K., Natsuaki, Y., Kawakami, T., Takeda, Y., Wang, W., Ishikawa, K., Goto, M., Koga, H., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.408 · Cited by 72
Disruption of Desmosome Assembly by Monovalent Human Pemphigus Vulgaris Monoclonal Antibodies
Mao, X., Choi, E. J., & Payne, A. S. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.339 · Cited by 72
Self-citationParaneoplastic pemphigus is associated with the DRB1*03 allele
Martel, P. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(02)00092-6 · Cited by 72
A Pathophysiologic Role for Epidermal Growth Factor Receptor in Pemphigus Acantholysis
Bektas, M., Jolly, P. S., Berkowitz, P., Amagai, M., & Rubenstein, D. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438010 · Cited by 68
Self-citationEnrichment of total serum IgG4 in patients with pemphigus
Funakoshi, T., Lunardon, L., Ellebrecht, C. T., Nagler, A. R., O’Leary, C. E., & Payne, A. S. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.11144.x · Cited by 63
Self-citationMAPKAP Kinase 2 (MK2)-Dependent and -Independent Models of Blister Formation in Pemphigus Vulgaris
Mao, X., Li, H., Sano, Y., Gaestel, M., Park, J. M., & Payne, A. S. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.224 · Cited by 61
Self-citationYamagami, J., Payne, A. S., Kacir, S., Ishii, K., Siegel, D. L., & Stanley, J. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci44425 · Cited by 58
Self-citationChen, Y., Chernyavsky, A. I., Webber, R. J., Grando, S. A., & Wang, P. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.668061 · Cited by 58
Sajda, T., Hazelton, J., Patel, M., Seiffert-Sinha, K., Steinman, L., Robinson, W. H., Haab, B. B., & Sinha, A. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525448113 · Cited by 57
Neonatal Autoimmune Blistering Disease: A Systematic Review
Zhao, C. Y., Chiang, Y. Z., & Murrell, D. F. (2016) · Pediatric Dermatology · doi:10.1111/pde.12859 · Cited by 56
Ectopic Expression of Epidermal Antigens Renders the Lung a Target Organ in Paraneoplastic Pemphigus
Hata, T., Nishimoto, S., Nagao, K., Takahashi, H., Yoshida, K., Ohyama, M., Yamada, T., Asano, K., & Amagai, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203536 · Cited by 54
Self-citationIdentification of a Functional Risk Variant for Pemphigus Vulgaris in the ST18 Gene
Vodo, D., Sarig, O., Geller, S., Ben‐Asher, E., Olender, T., Bochner, R., Goldberg, I., Nosgorodsky, J. S., Alkelai, A., Tatarskyy, P., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006008 · Cited by 53
Self-citationInvolvement of the Apoptotic Mechanism in Pemphigus Foliaceus Autoimmune Injury of the Skin
Li, N., Zhao, M., Wang, J., Liu, Z., & Diaz, L. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.711 · Cited by 51
Feldman, R. J., & Ahmed, A. R. (2011) · Expert Review of Clinical Immunology · doi:10.1586/eci.11.22 · Cited by 51
Takahashi, H., Amagai, M., Nishikawa, T., Fujii, Y., Kawakami, Y., & Kuwana, M. (2008) · Journal of Immunology · doi:10.4049/jimmunol.181.2.1526 · Cited by 50
Self-citationKasperkiewicz, M., Eming, R., Behzad, M., Hunzelmann, N., Meurer, M., Schulze‐Koops, H., von Wussow, P., Hertl, M., Zillikens, D., Freivogel, K., et al. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07931.x · Cited by 50
Self-citationTian, C., Luskin, G. K., Dischert, K. M., Higginbotham, J. N., Shepherd, B. E., & Crowe, J. E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.3279 · Cited by 48
Autoimmune diseases in patients with pemphigus and their first‐degree relatives
Leshem, Y. A., Katzenelson, V., Yosipovitch, G., David, M., & Mimouni, D. (2011) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2010.04818.x · Cited by 45
Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus
Vezzoli, P., Berti, E., & Marzano, A. V. (2008) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.4.3.351 · Cited by 43
Shah, A. D., Seiffert-Sinha, K., Sirois, D. A., Werth, V. P., Rengarajan, B., Zrnchik, W., Attwood, K. M., & Sinha, A. A. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1854 · Cited by 41
Weng, W., Weng, W., & Levy, R. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190903128660 · Cited by 35
AChR-specific immunosuppressive therapy of myasthenia gravis
Luo, J., & Lindstrom, J. M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.011 · Cited by 34
Luyet, C., Schulze, K., Sayar, B. S., Howald, D., Müller, E. J., & Galichet, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119809 · Cited by 32
Increased oxidative stress in pemphigus vulgaris is related to disease activity and HLA-association
Shah, A. A., Dey-Rao, R., Seiffert-Sinha, K., & Sinha, A. A. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1145675 · Cited by 31
Schmidt, T., Willenborg, S., Hünig, T., Deeg, C. A., Sønderstrup, G., Hertl, M., & Eming, R. (2015) · Experimental Dermatology · doi:10.1111/exd.12919 · Cited by 31
Cited by
Pathogenesis of autoimmune disease
Pisetsky, D. S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00720-1 · Cited by 649
Schmidt, E., Kasperkiewicz, M., & Joly, P. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31778-7 · Cited by 559
Self-citationJoly, P., Horvath, B., Patsatsi, Α., Uzun, S., Bech, R., Beissert, S., Bergman, R., Bernard, P., Borradori, L., Caproni, M., et al. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16752 · Cited by 363
Self-citationThe Unique Properties of IgG4 and Its Roles in Health and Disease
Rispens, T., & Huijbers, M. G. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00871-z · Cited by 282
Unmet medical needs in chronic, non-communicable inflammatory skin diseases
Ujiie, H., Rosmarin, D., Schön, M. P., Ständer, S., Boch, K., Metz, M., Maurer, M., Thaci, D., Schmidt, E., Cole, C., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.875492 · Cited by 158
Metadata
- Authors
- Kasperkiewicz, M., Ellebrecht, C. T., Takahashi, H., Yamagami, J., Zillikens, D., Payne, A. S., & Amagai, M.
- Venue
- Nature Reviews Disease Primers
- Published
- 2017-05-11
- Volume
- 3
- Issue
- 1
- Pages
- 17026-17026
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W4210972925
- Cited by
- 523
- References
- 108
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.